Weight-loss drug coverage for Illinois state workers could cost hundreds of millions of dollars – WBEZ (Chicago)

In making highly sought-after injectable medications like Wegovy, Mounjaro and Ozempic available to eligible enrollees in the state’s group health insurance program, Pritzker’s administration is seeking an estimated $210 million to fund the first full year of broadened coverage, starting July 1. The four-sentence provision was part of the 899-page budget approved the final day of the spring legislative session last May
9 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
Leaving Soon, just not soon enough
1 year ago

I work for the Government, the local, the State and the Federal government.
Combined they get over 50% of my earnings.

Riverbender
1 year ago

I hold both Eli Lilly and Novo Nordisk stock that are both doing quite well on the weight loss drug thing. With Pritzker types out there how can I lose investing in weight drugs?

Where's Mine ???
1 year ago

jbs the guy who needs to be hitten the ozempic

Last edited 1 year ago by Where's Mine ???
Where's Mine ???
1 year ago

Little discussed, but amongst other $gold plated$ deals jb has made remote/ work from home perminant for afscme….so you can supposedly be productively working from home off the couch while chowing down fast food 40hr a wk all on the taxpayers dime…..so yup, those poor afscme hero’s NEED their taxpayer afforded OZEMPIC….it’s a work place humanitarian rights issue!!!…(LLY up 7% on earnings this morning)

JackBolly
1 year ago

What about ‘Ozempic Face’? No consideration for paying for prescription drugs being used for an unintended, off-label, application which can have serious side effects. So when do IL taxpayers start paying for recreational pot for government workers?

Pensions Paid First
1 year ago
Reply to  JackBolly

“No consideration for paying for prescription drugs being used for an unintended, off-label, application which can have serious side effects.” While Ozempic is off label for weight loss, the exact same molecule is indicated under the name Wegovy. This is typically done because the FDA wants to treat them as separate drugs even know they are exactly the same. The FDA did the same thing 25 years ago with Wellbutrin (anti-depressant) when it was discovered that it also helped with smoking cessation. The FDA made the company have a separate name and called it Zyban. The real problem with these… Read more »

Freddy
1 year ago

Correct-I could go into great detail on repurposing drugs but it was not the case for Ivermectin which many said worked well within 12-24 hours but was not approved to treat Covid but was vilified. Did it work? Many said yes but trying to get an Rx was nearly impossible for fear of retribution. #1 reason. 40 cent per pill 4X’s/day for 5 days. Much cheaper than a vaccine or other medications. Anyway the root cause for obesity is never addressed. High Fructose Corn Syrup (HFCS). When HFCS was added decades ago to replace cane sugar obesity rates exploded. It… Read more »

debtsor
1 year ago

It’s one of those trade offs. Is loss of lean muscle worth the trade off of being 300lbs with a BMI of 50? IDK.

Pensions Paid First
1 year ago
Reply to  debtsor

The problem, that 300 pound person with 45 percent body fat drops 100 pounds, 40 of that is muscle and only 60 is from fat. Sure they weigh 200 pounds but their body fat composition only drops to 37.5 percent. If they gain back 25 pounds of fat and no muscle, they now weight 225 pounds and are back to almost 45 percent fat. They are no healthier than before and the metabolism is even worse so more weight gain is likely. These drugs are a good start but you will see in a couple years there will be drastic… Read more »

SIGN UP HERE FOR FREE WIREPOINTS DAILY NEWSLETTER

Home Page Signup
First
Last
Check what you would like to receive:

FOLLOW US

 

WIREPOINTS ORIGINAL STORIES

Mark Glennon on AM560’s Morning Answer: Chicago pension buyout plan mostly shifts debt rather than eliminating it, property tax surge doubles inflation over three decades

Chicago’s political leadership is floating a pension buyout program as evidence it is seriously addressing the city’s thirty-six-billion-dollar unfunded pension liability, but Mark Glennon, founder of the Illinois policy research organization Wirepoints, said that the proposal moves debt from one column to another rather than reducing it, and that the broader fiscal picture facing the city continues to deteriorate across every measurable dimension. Audio here.

Read More »

WE’RE A NONPROFIT AND YOUR CONTRIBUTIONS ARE DEDUCTIBLE.

SEARCH ALL HISTORY

CONTACT / TERMS OF USE